Verona Pharma plc (VRNA)
USD 40.06
(-3.84%)
USD 40.06
(-3.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 458 Thousand | 40 Million | - | 2351.00 | 2783.00 |
| Cost of Revenue | 679.62 Thousand | 346 Thousand | - | 627.84 Thousand | 512.11 Thousand | - |
| Gross Profit | -679.62 Thousand | 112 Thousand | 40 Million | -627.84 Thousand | -509.76 Thousand | 2783.00 |
| Operating Expenses | 67.15 Million | 66.22 Million | 97.68 Million | 66.01 Million | 53.41 Million | 32.48 Million |
| Selling, General and Administrative Expenses | 49.86 Million | 26.57 Million | 33.9 Million | 29.77 Million | 8.99 Million | 7.98 Million |
| Research and Development Expenses | 17.28 Million | 49.28 Million | 79.4 Million | 44.5 Million | 43.89 Million | 24.48 Million |
| Other Expenses | - | -9.63 Million | -15.63 Million | -8.26 Million | 527.08 Thousand | 16.49 Thousand |
| Cost and Expenses | 67.83 Million | 66.57 Million | 97.68 Million | 66.01 Million | 53.41 Million | 32.48 Million |
| Operating Income | -67.83 Million | -66.11 Million | -73.31 Million | -74.27 Million | -53.86 Million | -32.47 Million |
| Interest Expense | 2.06 Million | 521 Thousand | 340 Thousand | 35 Thousand | 221.58 Thousand | - |
| Income Tax Expense | -474 Thousand | 253 Thousand | -18 Thousand | 146 Thousand | -9.52 Million | -5.37 Million |
| Earnings before Tax | -55.21 Million | -68.44 Million | -55.58 Million | -65 Million | -51.4 Million | -30.62 Million |
| Net Income | -54.36 Million | -68.7 Million | -55.56 Million | -65.14 Million | -41.87 Million | -25.25 Million |
| Earnings Per Share Basic | -0.54 | -1.04 | -0.94 | -1.98 | -3.18 | -0.19 |
| Earnings Per Share Diluted | -0.54 | -1.04 | -0.94 | -1.98 | -3.18 | -0.19 |
| Weighted Average Shares Outstanding | 79.26 Million | 66.13 Million | 59.14 Million | 32.86 Million | 13.16 Million | 131.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.26 Million | 66.13 Million | 59.14 Million | 32.86 Million | 13.16 Million | 131.38 Million |
| Gross Margin | - | 0.24 | 1.00 | - | -216.83 | 1.00 |
| EBIT Margin | - | -136.81 | -1.43 | - | -22.01 Thousand | -11.23 Thousand |
| Profit Margin | - | -150.00 | -1.39 | - | -17.81 Thousand | -9073.85 |
| EBITDA | -52.46 Million | -67.29 Million | -42.18 Million | -47.81 Million | -32.16 Million | -25.49 Million |
| Earnings Before Tax Margin | - | -144.36 | -1.83 | - | -22.91 Thousand | -11.66 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.62 Million | - | - | 940.05 Thousand | - | - |
| Cost of Revenue | 543 Thousand | 270.3 Thousand | 262.84 Thousand | 209.8 Thousand | 679.62 Thousand | 154.1 Thousand |
| Gross Profit | 5.08 Million | -270.3 Thousand | -262.84 Thousand | 730.24 Thousand | -679.62 Thousand | -154.1 Thousand |
| Operating Expenses | 45.74 Million | 68.22 Million | 26.91 Million | 19.05 Million | 67.15 Million | 16.31 Million |
| Selling, General and Administrative Expenses | 35.19 Million | 48.81 Million | 20.15 Million | 14.89 Million | - | 13.35 Million |
| Research and Development Expenses | 10.55 Million | 19.4 Million | 6.76 Million | 4.15 Million | - | 2.95 Million |
| Other Expenses | - | 270.3 Thousand | - | 2.31 Million | - | - |
| Cost and Expenses | 46.29 Million | 68.49 Million | 27.18 Million | 19.26 Million | 67.83 Million | 16.31 Million |
| Operating Income | -40.66 Million | -68.49 Million | -27.18 Million | -19.26 Million | -67.83 Million | -14.73 Million |
| Interest Expense | -9.88 Million | 1.75 Million | 1.58 Million | 628.41 Thousand | 2.06 Million | -401 Thousand |
| Income Tax Expense | -250 Thousand | 167.18 Thousand | 168.9 Thousand | -1.09 Million | -632.44 Thousand | -44 Thousand |
| Earnings before Tax | -42.71 Million | -70.74 Million | -25.61 Million | -15.35 Million | -55.21 Million | -14.64 Million |
| Net Income | -42.96 Million | -70.91 Million | -25.77 Million | -14.25 Million | -54.57 Million | -14.68 Million |
| Earnings Per Share Basic | -0.53 | -0.88 | -0.32 | -0.18 | - | -0.18 |
| Earnings Per Share Diluted | -0.53 | -0.88 | -0.32 | -0.18 | - | -0.18 |
| Weighted Average Shares Outstanding | 81.02 Million | 81.02 Million | 80.71 Million | 80.26 Million | 79.26 Million | 79.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 81.02 Million | 81.02 Million | 80.71 Million | 80.26 Million | 79.26 Million | 79.77 Million |
| Gross Margin | 0.90 | - | - | 0.78 | - | - |
| EBIT Margin | -7.23 | - | - | -20.27 | - | - |
| Profit Margin | -7.64 | - | - | -15.16 | - | - |
| EBITDA | -40.66 Million | -68.22 Million | -26.91 Million | -19.05 Million | - | -14.73 Million |
| Earnings Before Tax Margin | -7.23 | - | - | -20.49 | - | - |
TRM
ATISHAY
VERK
TORVF
MNAP
GLKFF